Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease

Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

NCT02236728 ·Status: COMPLETED

Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

NCT02177357 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

NCT02248181 ·Status: COMPLETED

A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

NCT01149811 ·Status: COMPLETED

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

NCT02231255 ·Status: COMPLETED

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

NCT01096186 ·Status: COMPLETED ·Phase: PHASE3

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

NCT00036205 ·Status: TERMINATED ·Phase: PHASE3

Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease

NCT00240409 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

NCT00402233 ·Status: COMPLETED ·Phase: PHASE4

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease

NCT01097421 ·Status: COMPLETED

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

NCT00558025 ·Status: COMPLETED ·Phase: PHASE3

Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

NCT00666653 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate SYN115 in Parkinson's Disease

NCT00605553 ·Status: COMPLETED ·Phase: PHASE2

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

NCT00577460 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate in Patients With Parkinsonian Type Disorders

NCT03683225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease

NCT01711866 ·Status: COMPLETED ·Phase: PHASE4

A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

NCT00560508 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

NCT01130493 ·Status: COMPLETED ·Phase: PHASE3

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

NCT01191944 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

NCT02231294 ·Status: COMPLETED

A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa

NCT01140841 ·Status: COMPLETED

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

NCT02271503 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease

NCT02006290 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

NCT02172573 ·Status: COMPLETED ·Phase: PHASE3